Gerald Commissiong
Oprichter bij AMARANTUS BIOSCIENCE HOLDINGS, INC.
Profiel
Gerald E.
Commissiong founded Amarantus Bioscience Holdings, Inc. in 2008, where he is working as Executive Chairman & President from 2021.
Mr. Commissiong also currently works at Cutanogen Corp., as Chief Executive Officer, Todos Medical Ltd., as President, Chief Executive Officer & Director from 2020, Breakthrough Diagnostics, Inc., as Chief Executive Officer, Elto Pharma, Inc., as President, Secretary, Treasurer & Director, Provista Diagnostics, Inc., as President, and OS Therapies, Inc., as Chief Business Officer from 2024.
Mr. Commissiong also formerly worked at Jumpkicks, Inc., as Chief Operating Officer & Director in 2011 and Theralink Technologies, Inc. (Colorado), as Director.
Mr. Commissiong received his undergraduate degree from Stanford University.
Actieve functies van Gerald Commissiong
| Bedrijven | Functie | Begin |
|---|---|---|
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Oprichter | 14-01-2008 |
| TODOS MEDICAL LTD. | Algemeen Directeur | 05-01-2020 |
Cutanogen Corp.
 Cutanogen Corp. BiotechnologyHealth Technology Part of Gemini Strategies LLC, Inc., Cutanogen Corp. is a company that develops artificial skin products used to treat patients with severe burns. The company is based in Cincinnati, OH. The CEO of the company is Gerald E. Commissiong. Cutanogen was acquired by Amarantus Bioscience Holdings, Inc. from Lonza Group AG on July 15, 2015 for $9 million. | Algemeen Directeur | - |
Elto Pharma, Inc.
 Elto Pharma, Inc. Pharmaceuticals: MajorHealth Technology Elto Pharma, Inc. develops Eltoprazine, an oral small molecule 5HT1A/1B partial agonist in clinical development for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID), aggression in Alzheimer's disease and adult attention deficit hyperactivity disorder (adult ADHD).The company was founded on April 12, 2017 and is headquartered in Nevada, the United States of America. | President | - |
Breakthrough Diagnostics, Inc.
 Breakthrough Diagnostics, Inc. BiotechnologyHealth Technology Breakthrough Diagnostics, Inc. engages in the development of blood tests for the early detection of neurodegenerative disorders. Its primary product is the Lympro Test, a blood screening diagnostic test for Alzheimer’s disease. The company is headquartered in New York, NY. | Algemeen Directeur | - |
Provista Diagnostics, Inc.
 Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | President | - |
OS Therapies, Inc.
 OS Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services OS Therapies, Inc. operates as a clinical stage biopharmaceutical company. It engages in identification, development, and commercialization of treatments for Osteosarcoma and other related diseases. The company was founded by Paul A. Romness on April 12, 2018 and is headquartered in Rockville, MD. | Corporate Officer/Principal | 01-04-2024 |
Eerdere bekende functies van Gerald Commissiong
| Bedrijven | Functie | Einde |
|---|---|---|
Jumpkicks, Inc.
 Jumpkicks, Inc. Specialty StoresRetail Trade Jumpkicks, Inc. provides online retailing services. The company also provides content of interest to martial artists and selling products, such as uniforms, t-shirts, protective equipment, mats and other equipment and accessories. The company was founded on August 3, 2007 and is headquartered in Henderson, NV. | Operationeel Directeur | 08-06-2011 |
| AVANT DIAGNOSTICS INC | Directeur/Bestuurslid | - |
Opleiding van Gerald Commissiong
| Stanford University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Health Technology |
| TODOS MEDICAL LTD. | Health Technology |
 | Commercial Services |
| Bedrijven in privébezit | 6 |
|---|---|
Jumpkicks, Inc.
Jumpkicks, Inc. Specialty StoresRetail Trade Jumpkicks, Inc. provides online retailing services. The company also provides content of interest to martial artists and selling products, such as uniforms, t-shirts, protective equipment, mats and other equipment and accessories. The company was founded on August 3, 2007 and is headquartered in Henderson, NV. | Retail Trade |
Theralink Technologies, Inc. (Colorado)
 Theralink Technologies, Inc. (Colorado) Medical SpecialtiesHealth Technology Theralink Technologies, Inc. engages in the provision of biomarker assay services in the areas of oncology. The firm offers personalized medicine data through TheraLink assays to assist the biopharmaceutical industry and clinical oncologists in identifying drug treatments. It develops phosphoproteomic technologies that measure the activation status of signaling pathways. The company was founded on October 16, 2008 and is headquartered in Golden, CO. | Health Technology |
Cutanogen Corp.
Cutanogen Corp. BiotechnologyHealth Technology Part of Gemini Strategies LLC, Inc., Cutanogen Corp. is a company that develops artificial skin products used to treat patients with severe burns. The company is based in Cincinnati, OH. The CEO of the company is Gerald E. Commissiong. Cutanogen was acquired by Amarantus Bioscience Holdings, Inc. from Lonza Group AG on July 15, 2015 for $9 million. | Health Technology |
Elto Pharma, Inc.
Elto Pharma, Inc. Pharmaceuticals: MajorHealth Technology Elto Pharma, Inc. develops Eltoprazine, an oral small molecule 5HT1A/1B partial agonist in clinical development for the treatment of Parkinson's disease levodopa-induced dyskinesia (PD-LID), aggression in Alzheimer's disease and adult attention deficit hyperactivity disorder (adult ADHD).The company was founded on April 12, 2017 and is headquartered in Nevada, the United States of America. | Health Technology |
Breakthrough Diagnostics, Inc.
Breakthrough Diagnostics, Inc. BiotechnologyHealth Technology Breakthrough Diagnostics, Inc. engages in the development of blood tests for the early detection of neurodegenerative disorders. Its primary product is the Lympro Test, a blood screening diagnostic test for Alzheimer’s disease. The company is headquartered in New York, NY. | Health Technology |
Provista Diagnostics, Inc.
Provista Diagnostics, Inc. Miscellaneous Commercial ServicesCommercial Services Provista Diagnostics, Inc. operates as a diagnostic company. It focuses on the development and commercialization of proprietary blood based diagnostic, prognostic, and monitoring tests in women's cancer. Its products include videssa breast, ovarian, endometrial, and HPV associated. The company is headquartered in Alpharetta, GA. | Commercial Services |
